Biblio
“A Survey of Patient and Partner Outcome and Treatment Preferences in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1459-1468, 2018.
, “Supplementation with Matured Hop Bitter Acids Improves Cognitive Performance and Mood State in Healthy Older Adults with Subjective Cognitive Decline.”, J Alzheimers Dis, vol. 76, no. 1, pp. 387-398, 2020.
, “Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 90, no. 1, pp. 233-249, 2022.
, “Supplemental Retinal Carotenoids Enhance Memory in Healthy Individuals with Low Levels of Macular Pigment in A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.”, J Alzheimers Dis, vol. 61, no. 3, pp. 947-961, 2018.
, “A Super-Resolved View of the Alzheimer's Disease-Related Amyloidogenic Pathway in Hippocampal Neurons.”, J Alzheimers Dis, vol. 83, no. 2, pp. 833-852, 2021.
, “Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study.”, J Alzheimers Dis, vol. 93, no. 2, pp. 561-575., 2023.
, “Sulforaphane Inhibits the Generation of Amyloid-β Oligomer and Promotes Spatial Learning and Memory in Alzheimer's Disease (PS1V97L) Transgenic Mice.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1803-1813, 2018.
, “Successful Object Encoding Induces Increased Directed Connectivity in Presymptomatic Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1195-1205, 2017.
, “Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project.”, J Alzheimers Dis, 2018.
, “Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.”, J Alzheimers Dis, vol. 62, no. 1, pp. 165-174, 2018.
, “Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 1, pp. 231-42, 2015.
, “Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study.”, J Alzheimers Dis, vol. 85, no. 4, pp. 423-1439, 2021.
, “Subjective Sleep Quality is not Associated with Incident Dementia: The Rotterdam Study.”, J Alzheimers Dis, vol. 64, no. 1, pp. 239-247, 2018.
, “Subjective Memory Impairment and Gait Variability in Cognitively Healthy Individuals: Results from a Cross-Sectional Pilot Study.”, J Alzheimers Dis, vol. 55, no. 3, pp. 965-971, 2017.
, “Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
, “Subjective Cognitive Decline Prediction of Mortality: Results from the Einstein Aging Study.”, J Alzheimers Dis, vol. 66, no. 1, pp. 239-248, 2018.
, “Subjective Cognitive Decline, Objective Cognition, and Depression in Older Hispanics Screened for Memory Impairment.”, J Alzheimers Dis, vol. 63, no. 3, pp. 949-956, 2018.
, “Subjective Cognitive Decline May Be a Stronger Predictor of Incident Dementia in Women than in Men.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1469-1478, 2019.
, “Subjective Cognitive Decline Is Associated with Greater White Matter Hyperintensity Volume.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1283-1294, 2018.
, “Subjective Cognitive Decline: Is a Resilient Personality Protective Against Progression to Objective Cognitive Impairment? Findings from Two Community-Based Cohort Studies.”, J Alzheimers Dis, vol. 89, no. 1, pp. 87-105, 2022.
, “Subjective Cognitive Decline and APOE ɛ4: A Systematic Review.”, J Alzheimers Dis, vol. 65, no. 1, pp. 303-320, 2018.
, “Subjective Cognitive Complaints in Cognitively Healthy Older Adults and Their Relationship to Cognitive Performance and Depressive Symptoms.”, J Alzheimers Dis, vol. 59, no. 3, pp. 871-881, 2017.
, “Subclinical Doses of ATP-Sensitive Potassium Channel Modulators Prevent Alterations in Memory and Synaptic Plasticity Induced by Amyloid-β.”, J Alzheimers Dis, vol. 57, no. 1, pp. 205-226, 2017.
, “STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β Toxicity.”, J Alzheimers Dis, vol. 51, no. 2, pp. 391-403, 2016.
, “A Study of Amyloid-β and Phosphotau in Plaques and Neurons in the Hippocampus of Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 64, no. 2, pp. 417-435, 2018.
,